Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;24(3):206-212.

Early onset pancreatic cancer: a controlled trial

Bobby Tingstedt  1 , Carl Weitkämper  1 , Roland Andersson  1
Affiliations

Early onset pancreatic cancer: a controlled trial

Bobby Tingstedt et al. Ann Gastroenterol. 2011.

Abstract

Background: Pancreatic ductal adenocarcinoma (PDAC) represents the fourth cause of death in cancer with a 5-year survival rate of less than 1-2%. Early onset pancreatic cancer (EOPC), i.e. patients below 50 years of age, is infrequently described. The present study aimed to determine the epidemiology, demographic incidence and prognosis of EOPC and to identify the characteristics that might distinguish EOPC.

Methods: 576 consecutive patients with PDAC diagnosed from January 1993 to December 2008 at the University Hospital of Lund, Sweden. 65 different parameters were compared with a historic cohort of pancreatic cancer patients as well as with matched controls.

Results: 33 patients (5.7%) with PDAC were 50 years or younger. The overall survival was 170 days compared to 240 days for matched controls (p=n.s.). Patients with EOPC were diagnosed at a significantly more advanced stage, i.e. distant metastasis, (52%) as compared to matched controls (30%; p=0.04). EOPC-patients received more treatment than the compared PDAC-cohort.

Conclusion: EOPC constituted 5.7 % of all PDAC, presenting at an advanced stage with frequent metastases and poor survival. The role of genetic alterations and the potential influence of environmental factors for EOPC are to be further investigated.

Keywords: early onset; matched controls; outcome; pancreatic cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Survival of patients and controls
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M. Cancer statistics 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
    1. Jemal A, Clegg L, Ward E, et al. Annual report to the nation on the status of cancer 1975-2001, with a special feature regarding survival. CA Cancer J Clin. 2004;101:3–27. - PubMed
    1. Loos M, Kleeff J, Friess H, Büchler M. Surgical treatment of pancreatic cancer. Ann N Y Acad Sci. 2008;1138:169–180. - PubMed
    1. Andersson B, Aho U, Pendse M, Nilsson J, Tingstedt B, Andersson R. Gemcitabine treatment in pancreatic cancer - prognostic factors and outcome. Ann Gastroenterol. 2007;20:130–137.
    1. The National Board of Health and Welfare; Statistical databases of cancer; 2009. Jun, Socialstyrelsen. http://www.socialstyrelsen.se/Statistik/statistikdatabas/index.htm .

LinkOut - more resources